Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Galapagos Islands -- Ignore unavailable to you. Want to Upgrade?

To: farkarooski who wrote (20898)	1/11/2003 2:33:25 AM
From: Lazarus_Long	Read Replies (1) \| Respond to of 57110

LOL! We'd better enjoy this now because we'll be banned in the morning. :-)

To: farkarooski who wrote (20898)	1/11/2003 2:54:52 AM
From: stevenallen	Read Replies (1) \| Respond to of 57110

Zeta, you may be in grave danger! news.bbc.co.uk Saturday, 11 January, 2003, 00:00 GMT Clue to mystery Viagra deaths Viagra has been linked to a number of deaths The mystery behind the deaths of a small number of men taking the anti-impotence drug Viagra may have been solved by scientists. Although Viagra has achieved worldwide renown as a highly effective treatment for impotence, it was originally developed to prevent heart attacks and strokes. Our research suggests Viagra may present a risk for patients with pre-existing conditions Professor Xiaoping Du The drug was thought to work not only by dilating the blood vessels, but also by stopping tiny solid particles in the blood called platelets from clumping together and forming clots that could block blood flow and trigger a heart attack or stroke. However, new work by researchers from the University of Illinois at Chicago has found that the drug in fact has the reverse effect - it stimulates the clumping of platelets, thus raising the risk of clotting. Lead researcher Professor Xiaoping Du said: "Viagra, by itself, probably is not sufficient to cause a heart attack in healthy people, but our research suggests that it may present a risk for patients with pre-existing conditions such as atherosclerosis." Effect on cells The researchers tested the effect of Viagra on platelets taken from normal donors. Alone the drug did not stimulate the platelets to stick together. But it did if other compounds found in the bloodstream when the blood vessels are damaged - such as when somebody is suffering from heart disease - were added. In fact, under these conditions Viagra caused the platelets to clump together at concentrations well below those found in patients prescribed the drug as an impotence treatment. Viagra acts on platelets by inhibiting the breakdown of a compound found in cells called cyclic guanosine monophosphate (cGMP). For 20 years scientists have thought cGMP acts to stop platelet clumping. But the Chicago researchers believe that in fact cGMP initially causes platelets to clump together to seal a wound, only later reversing its effect to stop an excessive build-up that might block a blood vessel. In most circumstances, they argue this would work well. But a person at risk may already have blood vessels narrowed to the point that even the initial clumping of platelets could be enough to cause problems. Safety record Joel Morris, a spokesman for Pfizer, which makes Viagra, told BBC News Online that the drug had been shown to have a very impressive safety record. "We take this research seriously, and it will be scrutinised by our medical teams. "But a recent study by the Drug Safety Research Unit in the UK of 9,000 patients found that men who take Viagra are at no greater risk of heart problems than the general population." It is estimated that 20 million men worldwide have taken Viagra. The research is published in the journal Cell.